Michael Abramoff

Michael David Abràmoff (born 1963) is a Dutch-American ophthalmologist, computer scientist and entrepreneur. He is the Robert C. Watzke Professor of Ophthalmology and Visual Sciences at the Roy J. and Lucille A. Carver College of Medicine at the University of Iowa.[2] He is the Founder and Executive Chairman of IDx Technologies, Inc., of Iowa City, called by Wired Magazine "the bolder AI company",[3] and which received the first FDA marketing authorization for an autonomous diagnostic AI system in any field of medicine.[4]

Michael Abràmoff
Abramoff, 2018
Digital Diagnostics [1]Founder and Executive Chairman

Early life and education

Abràmoff was born in Rotterdam, the Netherlands, and received his MD and MS (information theory) from the University of Amsterdam.[5] He was a research fellow in the Neural Networks lab at RIKEN, Tokyo, Japan. He was Director of R&D at Prodix SA, an image analysis company in Paris, France. He performed his residency in ophthalmology at the University of Utrecht Academic Hospital, and his vitreoretinal fellowship at Vrije Universiteit in Amsterdam. He did his graduate research leading to a Ph.D. in medical image analysis at the University of Utrecht.[6]

Medical career

Abràmoff is referred to as "The Retinator," a nickname given to him in an Ophthalmology Times article,[7] referring to the work he has done on improving automated medical diagnostic algorithms.[8] One of his keynote addresses was on the role autonomous AI can play in improving healthcare productivity for SPIE Medical Imaging.[9]

Abràmoff is the author of over 300 peer-reviewed research articles, and his work has been cited over 33,000 times, leading to an h-index of 62 (Google Scholar)[10]. He is inventor on 19 US and international patents and patent applications primarily related to retinal imaging and machine learning.[11] Abramoff was also one of the early developers of ImageJ.[12][13]

Business career

Abràmoff founded three companies, EyeCheck, a teleretinal diabetic retinopathy screening company in Amsterdam, the Netherlands,[14] and i-Optics, an ophthalmic device company.[15] In 2010, he founded IDx LLC,[16] IDx, Technologies, Inc. now Digital Diagnostics[17] of which he is currently Executive Chairman.

In March 2016, IDx announced an Alliance for Eye Health with IBM Watson.[18] In January 2018 the results of its pivotal clinical trial for an AI-based autonomous system to detect diabetic retinopathy in primary care were submitted to FDA,[19] exceeding its pre-specified superiority endpoints for diagnostic accuracy. FDA assigned it breakthrough device status for expedited review.[20] He has been dubbed a "Renaissance Man" by Retina Physician[21] by creating a simple and more efficient process of analyzing images that is in the best interest of the patient.[22] It received the first FDA marketing authorization for an autonomous diagnostic AI system in any field of medicine.[23]

On October 25, 2017, in a Congressional Briefing sponsored by the Science Coalition, Abràmoff joined a panel of companies that, like IDx, spun out of U.S. research universities. The panelists highlighted to lawmakers the value of putting federal funds toward academic research.[24]

On November 13, 2018, Abràmoff was invited by the Federal Trade Commission to be a panelist for a hearing Understanding Algorithms, Artificial Intelligence, and Predictive Analytics Through Real World Applications. Abràmoff's panel explained how to do safe implementation of AI in medicine.[25]

Personal life

Outside of the world of medicine and science, Abràmoff was an interviewer for Spielberg’s Shoah Visual History Project.[26] He contributed to the Vance Integral Edition.[27]

Honors
  • 2020 University of Iowa Faculty/Staff Startup of the Year Award [28]
  • 2020 MedTech Breakthrough Award: Best New Technology Award - Diabetes Management[29]
  • 2019 Fellow, Institute of Electrical and Electonics Engineers (IEEE)[30]
  • 2019 CB Insights AI Top 100 list[31]
  • 2019 America’s Cultivation Corridor, Iowa Biotech Leader Award [32]
  • 2019 UI Carver College of Medicine Wall of Scholarship[33]
  • 2019 Ophthalmologist Top 10 Powerlist of Top Inventors[34]
  • 2018 Patent Award, University of Iowa Research Foundation[35]
  • 2018 Fellow, Association for Research in Vision and Ophthalmology (ARVO)[36]
  • 2016 Charles D. Phelps Memorial Award for Glaucoma Research[37]
  • 2013 Young Investigator Award, Macula Society[38]
  • 2011 President’s Innovation Award, American Telemedicine Association[39]
  • 2003 PG Binkhorst Award, "Objective Measurement of Motion in the Orbit"[40]
  • 2001 New Venture Award, McKinsey Inc. / Verbond Nederlandse Ondernemers, Award for Best Business plan, Netherlands[40]
  • 2002 3M-Jonkers Award[40]
  • 1996 RSNA Cum Laude Award, Congress of the Radiological Society of North America[41]
  • 1991 Peter Reichertz Prize for best young researcher, European Federation for Medical Informatics[40]

Selected publications
gollark: An unknown network error has occurred.
gollark: Sorry, my network link temporarily became apiobees.
gollark: I suppose there's significant latency.
gollark: Bogosort?
gollark: Œ

References
  1. Digital Diagnostics,
  2. "Michael Abramoff | Department of Ophthalmology and Visual Sciences". University of Iowa Carver College of Medicine. 2017. Retrieved March 24, 2017.
  3. "Using AI to Help Stroke Victims When 'Time Is Brain'". WIRED. Retrieved 2018-03-08.
  4. Commissioner, Office of the. "Press Announcements - FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems". www.fda.gov. Retrieved 2018-04-11.
  5. University of Iowa Carver College of Medicine, Department of Ophthalmology and Visual Sciences (2018). "Michael D. Abramoff, MD, PhD". medicine.uiowa.edu. Retrieved May 16, 2018.
  6. Abramoff, MD (20 September 2001). "Objective measurement of motion in the orbit". Utrecht University Repository. hdl:1874/395.
  7. McDonnell, P (July 1, 2010). "The Retinator: Revenge of the Machines". Ophthalmology Times. Retrieved Jan 18, 2017.
  8. Han, Ian C. (2017-05-01). "The Retinator II: Judgment Day?". OphthalmologyTimes. Retrieved 2018-03-08.
  9. SPIETV (February 23, 2012), Automated detection of retinal disease: when Moore's law meets Baumol's cost disease, retrieved Jan 16, 2017
  10. https://scholar.google.com/citations?user=O1b7GZMAAAAJ&hl=en
  11. "Michael D. Abràmoff - Google Scholar Citations". Google Scholar. Retrieved January 16, 2017.
  12. "Volume Rendering in Java - render". bij.isi.uu.nl. Retrieved 2018-05-16.
  13. Abràmoff, MD (2002). "Computation and Visualization of Three Dimensional Motion in the Orbit". IEEE Trans Med Imaging. 21 (4): 296–304. doi:10.1109/TMI.2002.1000254. PMID 12022618.
  14. Bassant, Eric (May 4, 2002). "Bureaucratie frustreert initiatief e-health". Het Financieele Dagblad, p.4.
  15. Oprichting i-Optics Nederland B.V. Oprichting Besloten Vennootschap. [available from] Westvest Netwerk Notarissen, Delft (www.westvest-notarissen.nl) [Uitgegeven voor afschrift. Mr K.J. Van den Dool, Delft Notaris]
  16. "IDx LLC". IDx LLC. Retrieved March 24, 2017.
  17. https://dxs.ai/
  18. Fiber, L (March 16, 2017). "IDx and IBM Watson Health Forge Alliance for Eye Health". IBM Press Release. Retrieved March 24, 2017.
  19. "A Breakthrough in Diagnosing Diabetic Retinopathy - JDRF". JDRF. 2018-02-05. Retrieved 2018-03-08.
  20. "The Association for Research in Vision and Ophthalmology- Trending topics". www.arvo.org. Retrieved 2018-03-08.
  21. "Retinal Physician - CONVERSATIONS IN RETINA: A Conversation With Michael Abràmoff, MD, PhD". Retinal Physician. Retrieved 2018-07-23.
  22. "HIStalk Interviews Michael Abràmoff, MD, PhD, President, IDx | HIStalk". histalk2.com. Retrieved 2018-07-23.
  23. Commissioner, Office of the. "Press Announcements - FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems". www.fda.gov. Retrieved 2018-07-23.
  24. Ophthalmology, University of Iowa (2017-10-30), UI physician briefs Congress on how research spurs economy, retrieved 2017-10-31
  25. https://www.healthcareitnews.com/news/ftc-hearing-not-all-ai-created-equal-so-safety-and-validation-are-critical
  26. Hoogendiuk, Oeke (May 24, 1996). "Zo groot, mooi en toegankelijk [So big, beautiful and accessible]". NIW: Nieuw Israelietisch Weekblad. 26(131): 26 (Steven Spielbergs Project pp 15-26).
  27. The Vance Integral Edition, archived from the original on May 20, 2016
  28. https://www.foriowa.org/iowa-stories/iowa-story.php?namer=true&isid=103
  29. https://medtechbreakthrough.com/2020-winners/
  30. https://services27.ieee.org/fellowsdirectory/getdetailprofile.html?custNum=ehCs7OeDCStbt%2BwlP6HAeQ%3D%3D&bccaptions=Alphabetical%20Listing%20&bclocations=%2Ffellowsdirectory%2Fhome.html
  31. https://www.cbinsights.com/research/2019-top-100-ai-startups-where-are-they-now/
  32. http://www.cultivationcorridor.org/abramoff-idx-receives-2019-cultivation-corridor-iowa-biotech-leader-award/
  33. https://medicine.uiowa.edu/research/wall-scholarship
  34. https://theophthalmologist.com/power-list/2019
  35. https://research.uiowa.edu/impact/news/awards-program-honors-university-researchers-and-innovators
  36. https://www.arvo.org/awards-grants-and-fellowships/arvo-fellows2/2018-fellows/
  37. Department of Ophthalmology and Visual Sciences, UI (2017). "Charles D. Phelps Memorial Award". medicine.uiowa.edu. Retrieved May 16, 2018.
  38. The Macula Society (2018). "Young Investigator Award". www.maculasociety.org. Retrieved May 16, 2018.
  39. American Telemedicine Association (2018). "ATA President's Awards Recipients - ATA Main". www.americantelemed.org. Retrieved May 16, 2018.
  40. Abramoff, MD (Oct 1, 2004). "Michael D. Abramoff, Personal information". bij.isi.uu.nl. Retrieved May 16, 2018.
  41. Jongkind, Liesbeth (1997). "Ik zie wat jij niet ziet". SCAN: Uitgave van Het Medisch Netwerk Utrecht (2): 22–23. ISSN 1385-2167.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.